FDA clears Abbott high sensitivity troponin-I test

Create PDF

”As one of the most widely researched high sensitivity troponin tests, this technology could help address several challenges in emergency departments today, including overcrowding and more accurately identifying heart attacks in women,” Agim Beshiri, MD, Abbott’s senior medical director of global medical and scientific affairs, diagnostics, said in a company press release.

Abbott, 224-667-6100